Cornerstone Therapeutics (CRTX)
Add to Watchlists Create an AlertCRTX Key Stats
| Income Statement | |
| Revenue TTM | 131.90M |
| Revenue Quarterly YoY Growth | 71.38% |
| EPS Diluted TTM | -0.2942 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -7.648M |
| Profitability | |
| Gross Profit Margin Quarterly | 67.99% |
| Profit Margin Quarterly | 6.36% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 226.63M |
| Enterprise Value | 252.81M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 1.336 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.528 |
| Free Cash Flow | 8.025M |
| Return on Equity | -4.48% |
CRTX News
- Nasdaq stocks posting largest percentage increases May 20
- Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Prop... May 14
- Cornerstone Therapeutics Management Discusses Q1 2013 Results - Earnings Call Tr... May 9
- CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitiv... May 9
- Q1 2013 Cornerstone Therapeutics Inc. Earnings Release - Before Market Open May 9
- Cornerstone Therapeutics Reports First Quarter 2013 Financial Results Marketwired May 9
- Cornerstone (CRTX) Acquires U.S. Marketing Rights to PERTZYE Street Insider May 9
- Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) ... May 9
- Zacks #5 Rank Additions for Thursday - Tale of the Tape Zacks May 9
- REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call Marketwired May 8
CRTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cornerstone Therapeutics is up 69.54% over the last year vs S&P 500 Total Return up 27.77%, Insmed up 331.0%, and China Biologic Products up 234.4%.
CRTX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these CRTX related companies
Pro Ratings for CRTX
Pro Report PDF for CRTX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download CRTX Pro Report PDF
Pro Strategies Featuring CRTX
Did Cornerstone Therapeutics make it into our Pro Portfolio Strategies?
CRTX Profile
Sector: Healthcare
Industry: Biotechnology
Other CRTX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CRTX | 8.46 | +0.05 | +0.59% | 226.63M |
